Latest News for: hdv

Edit

Diasorin has been granted De novo authorization in the U.S. for the First Fully Automated Laboratory Test for Hepatitis Delta Virus (HDV) on the LIAISON XL (DiaSorin SpA)

Public Technologies 29 Jan 2026
for the First Fully Automated Laboratory Test for Hepatitis Delta Virus (HDV) on the LIAISON XL. The New LIAISON XL murex anti-HDV Assay is the first fully automated immunoassay that has been granted de novo authorization for HDV detection in the U.S.
Edit

Structural characterization of the HDV virion and its ribonucleoprotein

PNAS 21 Jan 2026
SignificanceChronic Hepatitis D virus (HDV) infection represents ...
Edit

BCN HEALTH has presented several communications at the EASL and AASLD congresses evaluating the clinical and economic burden of patients with HDV coinfection and HBV monoinfection in Spain (ASEBIO - Asociación Española de Bioempresas)

Public Technologies 16 Dec 2025
[...]. This is an abstract of the document. To keep reading, click here and get access to the original version ... Disclaimer.
Edit

Replicor publishes data from its compassionate access program in HBV/HDV

Times Argus 08 Dec 2025
MONTREAL, Dec. 7, 2025 /PRNewswire/ - Replicor Inc. announced the publication of data from its first global compassionate access program in the Journal of Hepatology (see here) ....
Edit

Vir Biotechnology Announces AASLD The Liver Meeting® Presentation & New England Journal of Medicine Publication of Phase 2 Data Demonstrating Tobevibart & Elebsiran Combination Deliver High Rates of Undetectable HDV RNA with Favorable Safety Profile (Vir Biotechnology Inc)

Public Technologies 09 Nov 2025
SOLSTICE trial data demonstrate that 66% of chronic hepatitis delta participants receiving a monthly dose of tobevibart and elebsiran achieved undetectable HDV RNA at Week 48 ... high baseline HDV RNA.
  • 1

Article Search

tools
×
×
×
×